We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+0.8%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$796M
AUM Growth
-$185M
Cap. Flow
-$163M
Cap. Flow %
-20.42%
Top 10 Hldgs %
3.37%
Holding
1,987
New
622
Increased
338
Reduced
393
Closed
624

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$5.34M
2
MSFT icon
Microsoft
MSFT
+$5.22M
3
OPLN
Openlane
OPLN
+$4.6M
4
AAPL icon
Apple
AAPL
+$4.51M
5
HRI icon
Herc Holdings
HRI
+$4.09M

Sector Composition

Rank Sector Weight
1 Healthcare 16.45%
2 Industrials 15.7%
3 Technology 14.88%
4 Consumer Discretionary 11.13%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEEL
1876
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
-21
Closed -$195K
TELL
1877
DELISTED
Tellurian Inc.
TELL
-10,497
Closed -$41K
VTNR
1878
DELISTED
Vertex Energy, Inc
VTNR
-10,717
Closed -$56K
VGR
1879
DELISTED
Vector Group Ltd.
VGR
-61,205
Closed -$553K
PRFT
1880
DELISTED
Perficient Inc
PRFT
-2,550
Closed -$295K
SWN
1881
DELISTED
Southwestern Energy Company
SWN
-129,902
Closed -$720K
HA
1882
DELISTED
Hawaiian Holdings, Inc.
HA
-64,833
Closed -$1.4M
EGIO
1883
DELISTED
Edgio, Inc. Common Stock
EGIO
-21,294
Closed -$2.03M
SPWR
1884
DELISTED
SunPower Corporation Common Stock
SPWR
-10,576
Closed -$240K
TWOU
1885
DELISTED
2U Inc
TWOU
-1,246
Closed -$1.25M
CONN
1886
DELISTED
Conn's Inc.
CONN
-27,230
Closed -$622K
CERE
1887
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
-25,942
Closed -$765K
SLCA
1888
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
-52,991
Closed -$423K
TCON
1889
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
-4,300
Closed -$333K
BIOL
1890
DELISTED
Biolase, Inc.
BIOL
-502
Closed -$802K
AVGR
1891
DELISTED
Avinger, Inc. Common Stock
AVGR
-964
Closed -$215K
LBAI
1892
DELISTED
Lakeland Bancorp Inc
LBAI
-60,821
Closed -$1.07M
SP
1893
DELISTED
SP Plus Corporation
SP
-20,612
Closed -$632K
TTOO
1894
DELISTED
T2 Biosystems, Inc
TTOO
-33
Closed -$152K
NBSE
1895
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
-17,559
Closed -$1.27M
AEL
1896
DELISTED
American Equity Investment Life Holding Company
AEL
-8,761
Closed -$259K
KAMN
1897
DELISTED
Kaman Corp
KAMN
-36,360
Closed -$1.3M
MDRX
1898
DELISTED
Veradigm Inc. Common Stock
MDRX
-53,980
Closed -$722K
MARK
1899
DELISTED
Remark Holdings, Inc.
MARK
-46,670
Closed -$490K
GOL
1900
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
-16,755
Closed -$128K

Similar funds

GSA Capital Partners's Q4 2021 Portfolio in Review

As of Q4 2021, GSA Capital Partners held 1,987 positions worth $796M, down 19% from $982M the previous quarter. Its ten largest holdings account for 3.4% of the portfolio.

GSA Capital Partners withdrew a net $163M in Q4 2021, closing 624 positions and reducing 393 holdings. Its most notable exit was Morgan Stanley, an estimated $5.34M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.

Against the trend, GSA Capital Partners opened a new position in Genius Sports worth $2.45M.

  • GSA Capital Partners's largest Q4 2021 buy was Genius Sports: 322,717 shares worth $2.45M.
  • GSA Capital Partners added most to State Street Consumer Staples Select Sector SPDR ETF in Q4 2021, an estimated $2.43M increase.
  • GSA Capital Partners's biggest Q4 2021 reduction was Microsoft, cutting an estimated $5.22M.
  • GSA Capital Partners fully exited Morgan Stanley in Q4 2021, selling an estimated $5.34M.
  • GSA Capital Partners's ten largest holdings make up 3.4% of its $796M portfolio in Q4 2021.
  • GSA Capital Partners opened 622 new positions and closed 624 in Q4 2021.
  • GSA Capital Partners's portfolio value fell 19% quarter-over-quarter to $796M.

Based on GSA Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.